Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer-Reference-Cited by-同舟云学术

Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer

Published:2017-08-02 Issue:42 Volume:8 Page:72447-72456
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Qi¹²,Li Ruichao²,Chen Xu¹²,Lee Sang Beom²,Pan Jing¹²,Xiong Donghai¹²,Hu Jiaqi²,Miller Mark Steven³,Szabo Eva³,Lubet Ronald A.³,Wang Yian¹²,You Ming¹²

Affiliation:

1. Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA

2. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA

3. Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD 20850, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of pharmacolipidodynamic effects following the intravenous and oral administration of gefitinib to C57Bl/6JRj mice by rapid UHPLC-MS analysis of plasma;Scientific Reports;2024-07-24

2. Detection of Pharmacolipidodynamic Effects Following the Intravenous and Oral Administration of Gefitinib to C57Bl/6JRj Mice by Rapid UHPLC/MS Analysis of Plasma;2023-10-04

3. Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations;Frontiers in Cell and Developmental Biology;2023-04-24

4. Working with Convex Responses: Antifragility from Finance to Oncology;Entropy;2023-02-13

5. The β-Blocker Carvedilol Prevents Benzo(a)pyrene-Induced Lung Toxicity, Inflammation and Carcinogenesis;Cancers;2023-01-18